CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase II Study of Olaparib in Patients With Advanced Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04042831
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:32.269034+00:00
- Published At
- 2023-10-13T00:00:00+00:00
- Record Updated At
- 2023-10-13
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Bile Duct Adenocarcinoma", "Fanconi Anemia Complementation Group Gene Mutation", "Metastatic Bile Duct Carcinoma", "PTEN Gene Deletion"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-10-13"- protocolSection.identificationModule.nctId
"NCT04042831"- protocolSection.identificationModule.officialTitle
"A Phase II Study of Olaparib in Patients With Advanced Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.